Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Vistagen Therapeutics, Inc. (VTGN)

Compare
2.3900
+0.0500
+(2.14%)
At close: 4:00:00 PM EDT
2.3800
-0.01
(-0.42%)
After hours: 4:58:30 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 234k
Earnings -14.09M

Q1'24

Q2'24

Q3'24

Q4'24

-10M
-5M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

12.00
13.00 Average
2.3900 Current
15.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2122
Avg. Estimate -0.49-0.32-1.74-1.34
Low Estimate -0.53-0.32-1.77-1.39
High Estimate -0.45-0.32-1.7-1.29
Year Ago EPS -0.25-0.35-1.52-1.74

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4144
Avg. Estimate 182k--657.5k321.75k
Low Estimate ----500k--
High Estimate 628k--1.13M1.29M
Year Ago Sales 197.3k84k1.06M657.5k
Sales Growth (year/est) -7.75%-100.00%-38.20%-51.06%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.33-0.41-0.38-0.52
EPS Actual -0.25-0.35-0.42-0.46
Difference 0.080.06-0.040.06
Surprise % 24.24%13.58%-10.53%11.54%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.49-0.32-1.74-1.34
7 Days Ago -0.52-0.36-1.82-1.48
30 Days Ago -0.52-0.36-1.82-1.48
60 Days Ago -0.52-0.36-1.82-1.48
90 Days Ago -0.52-0.36-1.82-1.48

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1122
Up Last 30 Days 1122
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
VTGN -96.00%8.57%-14.14%22.77%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Upgrade Jefferies: Hold to Buy 12/7/2023
Initiated Stifel: Buy 11/14/2023
Maintains Maxim Group: Buy to Buy 9/5/2023
Upgrade Maxim Group: Hold to Buy 8/7/2023

Related Tickers